Vera Labitzky

422 total citations
13 papers, 141 citations indexed

About

Vera Labitzky is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Vera Labitzky has authored 13 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and Allergy and 4 papers in Oncology. Recurrent topics in Vera Labitzky's work include Cell Adhesion Molecules Research (6 papers), 3D Printing in Biomedical Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Vera Labitzky is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), 3D Printing in Biomedical Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Vera Labitzky collaborates with scholars based in Germany, United States and Switzerland. Vera Labitzky's co-authors include Udo Schumacher, Tobias Lange, Daniel Wicklein, Leticia Oliveira‐Ferrer, Barbara Schmalfeldt, Wolfgang H. Krautschneider, Yi� Ding, Karen Legler, Yen‐Lin Huang and Peter Valent and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vera Labitzky

13 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Labitzky Germany 9 77 39 37 28 21 13 141
Karina Vázquez-Arreguín United States 6 88 1.1× 58 1.5× 35 0.9× 24 0.9× 4 0.2× 10 180
Sophie Léon France 4 92 1.2× 64 1.6× 24 0.6× 23 0.8× 14 0.7× 4 167
Philip Bland United Kingdom 6 112 1.5× 34 0.9× 41 1.1× 16 0.6× 10 0.5× 8 210
Michelle Rowicki China 3 132 1.7× 86 2.2× 48 1.3× 33 1.2× 29 1.4× 3 218
Tomás A. Martins Switzerland 5 89 1.2× 68 1.7× 41 1.1× 20 0.7× 13 0.6× 8 198
Natalie L. Kingston United States 5 86 1.1× 103 2.6× 35 0.9× 29 1.0× 13 0.6× 6 196
Ji Shi China 10 175 2.3× 53 1.4× 90 2.4× 28 1.0× 7 0.3× 20 282
Salah Almokadem United States 5 67 0.9× 73 1.9× 29 0.8× 19 0.7× 66 3.1× 9 154
Gaurav Sharma United States 7 127 1.6× 91 2.3× 52 1.4× 31 1.1× 6 0.3× 18 257
Hanna Maar Germany 8 106 1.4× 125 3.2× 42 1.1× 46 1.6× 31 1.5× 16 235

Countries citing papers authored by Vera Labitzky

Since Specialization
Citations

This map shows the geographic impact of Vera Labitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Labitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Labitzky more than expected).

Fields of papers citing papers by Vera Labitzky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Labitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Labitzky. The network helps show where Vera Labitzky may publish in the future.

Co-authorship network of co-authors of Vera Labitzky

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Labitzky. A scholar is included among the top collaborators of Vera Labitzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Labitzky. Vera Labitzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Häupl, Björn, Vera Labitzky, Stefan Küffer, et al.. (2022). Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer. npj Precision Oncology. 6(1). 52–52. 11 indexed citations
2.
Tilki, Derya, Anna Suling, Oliver Hahn, et al.. (2021). CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo. Cancer Gene Therapy. 29(1). 49–61. 7 indexed citations
3.
Huang, Yen‐Lin, Ching-Yeu Liang, Vera Labitzky, et al.. (2021). Site-specific N-glycosylation of integrin α2 mediates collagen-dependent cell survival. iScience. 24(10). 103168–103168. 18 indexed citations
4.
Ding, Yi�, Vera Labitzky, Karen Legler, et al.. (2021). Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer. Molecular Oncology. 15(12). 3578–3595. 22 indexed citations
5.
Labitzky, Vera, Ronald Simon, Guido Sauter, et al.. (2021). Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets. Molecular Oncology. 15(7). 1956–1969. 7 indexed citations
6.
Lange, Tobias, Vera Labitzky, Kristoffer Riecken, et al.. (2020). The initial engraftment of tumor cells is critical for the future growth pattern: a mathematical study based on simulations and animal experiments. BMC Cancer. 20(1). 524–524. 9 indexed citations
7.
Labitzky, Vera, Anke Baranowsky, Hanna Maar, et al.. (2020). Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice. Cancers. 12(2). 385–385. 12 indexed citations
8.
Labitzky, Vera, et al.. (2020). Use of Electrical Impedance Spectroscopy to Distinguish Cancer from Normal Tissues with a Four Electrode Terminal Setup. SHILAP Revista de lepidopterología. 6(3). 341–344. 8 indexed citations
9.
Maar, Hanna, Vera Labitzky, Daniel Wicklein, et al.. (2020). Systematic analysis of the human tumor cell binding to human vs. murine E- and P-selectin under static vs. dynamic conditions. Glycobiology. 30(9). 695–709. 14 indexed citations
10.
Labitzky, Vera, et al.. (2019). Electrical Impedance Spectroscopy for Characterization of Prostate PC-3 and DU 145 Cancer Cells. PubMed. 2019. 6485–6489. 3 indexed citations
11.
Lange, Tobias, Ursula Valentiner, Daniel Wicklein, et al.. (2016). E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.. Journal of Clinical Oncology. 34(15_suppl). e23010–e23010. 1 indexed citations
12.
Oliveira‐Ferrer, Leticia, Vera Labitzky, Daniel Wicklein, et al.. (2015). Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties. Journal of Cancer Research and Clinical Oncology. 141(10). 1715–1726. 16 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karina Vázquez-Arreguín Breakdown of academic impact, for papers by Sophie Léon Breakdown of academic impact, for papers by Philip Bland Breakdown of academic impact, for papers by Michelle Rowicki Breakdown of academic impact, for papers by Tomás A. Martins Breakdown of academic impact, for papers by Natalie L. Kingston Breakdown of academic impact, for papers by Ji Shi Breakdown of academic impact, for papers by Salah Almokadem Breakdown of academic impact, for papers by Gaurav Sharma Breakdown of academic impact, for papers by Hanna Maar
Rankless by CCL
2026